Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jaymin Upadhyay has a total of 244 co-authors. Here are the top co-authors by number of shared publications:

  • Mariesa Cay

    Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, USA

    14 shared publications
  • Emma Golden

    Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, USA

    13 shared publications
  • Raquel van Gool

    Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, USA

    13 shared publications
  • Hanne van der Heijden

    Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, USA

    10 shared publications
  • Amanda Cao

    Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, USA

    8 shared publications
  • Benjamin Goodlett

    Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    8 shared publications

Latest Publications

  • Prefrontal circuitry abnormalities and cognitive impairment in adolescents with early-onset psychosis

    by Hanne van der Heijden, Saad Rahmat, Amanda Cao, Raquel van Gool, Merve Koç Yekedüz, Lise Vrolix, Talia Barrett, Edin T. Randall, Itamar Ronen, James Barnacle, et al.

  • Nociceptive responses and resting-state functional connectivity of the human midbrain tegmentum

    by Amanda Cao, Kiely Morris, Hanne van der Heijden, Raquel van Gool, Shantel Rose Gregory, Joseph Gonzalez-Heydrich, Daniel Paech, Sabina Berretta, Jaymin Upadhyay

  • Open Access

    Evaluation of Electrical Impedance Myography as a Noninvasive Musculoskeletal Biomarker in Infantile- and Late-Onset Pompe Disease

    by Raquel van Gool, Nehal Shah, Amanda Cao, Lise Vrolix, Buket Sonbas Cobb, Benjamin Goodlett, Georgina Johnson, Hanne van der Heijden, Merve Koç Yekedüz, Carlos Camelo, et al.

  • Open Access

    Intensive, Interdisciplinary Pain Treatment in Fibrous Dysplasia/McCune-Albright Syndrome

    by Camryn Berry, Edin Randall, Julie Shulman, Shealyn O’DOnnell, Catherine E Stewart, Jen Christofferson, Kevin Zirko, Ana Gallotto, Eleanor Powell, Zachary S Peacock, et al.

    Pain in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) remains inadequately treated. The pilot study was aimed to determine the feasibility (ie, completion, retention, and acceptability) and explore the effectiveness of an intensive interdisciplinary pain treatment (IIPT) using a biopsychosocial approach in patients with FD/MAS. Five patients (4 Females, 1 Male; 22-30 yr old) with FD/MAS, with baseline pain severity of 4+ (0-10 scale) were enrolled. A three-week intervention (4 d/wk; 3-4 h/d) integrating psychological, physical, and occupational therapies was administered to patients. Study measures included patient-reported outcomes at treatment admission (week 0), discharge (week 3), and follow-up (week 15). Physician global assessments (PGA) at weeks 0 and 3 were also collected. All five patients completed the 3-wk intervention and follow-up assessment and reported a high degree of acceptability, appropriateness, and feasibility of the intervention. Average pain severity decreased after treatment, with mean changes of −3.0 and − 3.2 points at weeks 3 and 15, respectively. Patients demonstrated improvements in pain interference, external pain expression (measured with the pain behavior scale), and pain catastrophizing. Trends of decreased anxiety and depression were observed. Overall health-related quality of life improved at treatment discharge, which was consistent with the PGA (ie, +2 to +3) scores. This pilot study demonstrates that IIPT was feasible and showed initial clinical benefit across multiple dimensions in a small cohort of patients with FD/MAS. Larger-scale, controlled trials are needed for further validation.

  • Open Access

    Prefrontal Circuitry Abnormalities and Cognitive Impairment in Adolescents with Early- Onset Psychosis

    by Hanne Van Der Heijden, Saad Rahmat, Amanda Cao, Raquel van Gool, Merve Koç Yekedüz, Lise Vrolix, Talia Barrett, Edin T. Randall, Itamar Ronen, James Barnacle, et al.

    Early-onset psychosis (EOP) is associated with marked cognitive impairment and poorer health-related and psychosocial outcomes compared to adult-onset illness, yet the neural mechanisms underlying these deficits during adolescence remain incompletely understood. Despite evidence implicating dorsolateral prefrontal cortex (dlPFC) dysfunction, the region’s functional and structural correlates in youth with EOP are not well characterized. Adolescents with EOP (N=31) and healthy controls (HC; N=20) completed NIH Toolbox cognitive assessments and PROMIS self-reports. Prefrontal function was assessed using functional near-infrared spectroscopy (fNIRS) during a Stroop task and at rest. Multimodal MRI, including resting-state fMRI, diffusion tensor imaging, and structural imaging, was used to examine connectivity and morphology of prefrontal and fronto-cerebellar circuits. Adolescents with EOP exhibited poorer cognitive performance across executive functioning domains compared to HC. fNIRS revealed reduced right dlPFC activation on a cognitive control paradigm (p=0.007) and increased resting-state connectivity between right dlPFC and ventrolateral PFC (p=0.02). Furthermore, resting-state fMRI showed increased dlPFC-striatal connectivity and reduced connectivity with cerebellar Crus I/II (p-FDR<0.05). White matter integrity of the superior longitudinal fasciculus correlated with dlPFC activation during task performance. Structural analyses identified reduced frontal cortical thickness and decreased cerebellar Crus II volumes (p-FWE<0.05) in patients with EOP, with frontal morphology associating with cognitive measures. In summary, cognitive impairment in adolescents with EOP is associated with convergent abnormalities in dlPFC function, fronto-striatal connectivity, and fronto-cerebellar structure. These findings support a model of disrupted prefrontal circuit maturation in EOP and highlight multimodal imaging markers with potential relevance for early identification and targeted intervention.

  • Open Access

    Multimodal Non-Invasive Biomarker Characterization of Structural and Functional Alterations in ADSS1 Myopathy

    by Merve Koç Yekedüz, Raquel van Gool, Hanne van der Heijden, Buket Sonbas Cobb, Nehal Shah, Georgina Johnson, Cara A Timpani, Julie Shulman, Vanessa Rameh, Evan E Hsu, et al.

    Adenylosuccinate synthetase 1 (ADSS1) myopathy is an ultra-rare disease characterized by progressive muscle dysfunction. The objective of this investigation was to employ a non-invasive biomarker approach to phenotype (fine-)motor skills, speech production and cognition in adults with ADSS1 myopathy. Five individuals with ADSS1 myopathy and five age-sex-matched healthy controls (HCs) underwent a comprehensive multimodal evaluation. Assessments included, (i) evaluation of motor performance, (ii) speech production and cognitive test batteries, (iii) patient-reported outcomes, (iv) electrical impedance myography (EIM), (v) musculoskeletal magnetic resonance imaging (MRI) and (vi) plasma proteomics. ADSS1 participants vs. HCs demonstrated reduced performance on the 9-Hole Peg and grip strength tests as well as lower self-reported mobility. Speech production analysis revealed asthenia (p=0.02), lower intelligibility (p=0.008), and worse voice quality during the sustained vowel task (p=0.03) in the ADSS1 cohort. Cognitive functioning remained unaffected in patients with ADSS1. On EIM, ADSS1 participants vs. HCs, demonstrated a pattern of higher resistance and lower reactance and phase across upper- and lower-extremity measurements, indicative of poorer muscle health, with large effect sizes (Cliff’s 8=0.5-0.9). MRI revealed intramuscular fat infiltration, particularly in posterior compartments of the upper leg (e.g., biceps femoris). Proteomics indicated reduced (p=0.04) Neurotrophin-3 (NTF3; implicated in neuronal development, survival and differentiation) levels in the ADSS1 cohort relative to HCs. Lower NTF3 levels associated with poorer performance on hand-motor tasks as well as higher resistance and lower reactance and phase on EIM. This study highlighted the value of multimodal phenotyping for quantifying disease expression and advancing monitoring strategies in ADSS1 myopathy. Take-home message: This multimodal investigation demonstrates that integrating electrical impedance myography with quantitative motor, speech, musculoskeletal imaging, and proteomic assessments provides a sensitive and non-invasive research framework for capturing neuromuscular dysfunction and functional disease burden in patients with ADSS1 myopathy, thereby supporting the current biomarker strategy for refined phenotyping and longitudinal disease monitoring in this ultra-rare condition.

  • Open Access

    Fronto-cerebellar features associate with cognitive dysfunction in childhood-onset systemic lupus erythematosus

    by Hanne Van der Heijden, Gabrielle Alonzi, Amanda Cao, Raquel van Gool, Merve Koç Yekedüz, Lise Vrolix, Itamar Ronen, Vanessa Rameh, Kyle McBrearty, Aditi Deokar, et al.


  • Open Access

    Associations between negative symptoms and thermal pain perception in bipolar I disorder

    by Lise Vrolix, Jon Haitz Legarreta, Hanne van der Heijden, Raquel van Gool, Aliza Ray, Emma Golden, Mariesa Cay, Yogesh Rathi, Joseph Gonzalez-Heydrich, Lauren J. O’dOnnell, et al.

    There is emerging evidence that negative symptoms are a source of functional impairment for individuals with bipolar I disorder (BD). Patients with BD may


  • Open Access

    Diffusion Tensor Imaging Reveals Altered Centrality of Pain‐Related Regions in SCN9A‐Associated Small Fiber Neuropathy

    by Gerhard S. Drenthen, Dennis Kool, Amir Far, Jaymin Upadhyay, David E. J. Linden, Raquel van Gool, Celine P. Goijen, Ingemar S. J. Merkies, Walter H. Backes, Catharina G. Faber, et al.

    Background and Purpose: Small fiber neuropathy (SFN) is a neuropathic disorder that is associated with chronic pain. While most SFN cases are idiopathic, SFN can also have hereditary causes. For example, rare SCN9A gene mutations can impair the Na V 1.7 sodium channel, which leads to dorsal root ganglion neuron hyperexcitability, causing SFN. Although chronic pain may induce cerebral changes, the specific structural brain alterations in SCN9A‐associated SFN (SFN‐SCN9A) remain insufficiently characterized. Therefore, potential alterations in the structural brain network of idiopathic SFN and SFN‐SCN9A were explored. Methods: Ten SFN‐SCN9A patients, 20 idiopathic SFN patients, and 20 controls were included. All participants underwent 3‐Tesla diffusion MRI (66 gradient directions, b ‐value = 1200 s/mm 2 ), and the brain network was quantified using nodal importance, which describes the influence of a group of regions on the whole network. Results: The nodal importance of pain‐associated regions (postcentral gyrus, insular cortex, anterior cingulate cortex, and thalamus) was increased in SFN‐SCN9A patients compared to controls ( β = 0.43, p = 0.02) and idiopathic SFN patients ( β = 0.43, p = 0.02). Moreover, higher self‐reported pain was associated with higher nodal importance of pain‐associated regions in the SFN‐SCN9A group ( r = 0.67, p = 0.03), while this effect was not observed in the idiopathic SFN patients ( r = −0.22, p = 0.34). As self‐reported pain did not differ between the SFN groups, it is likely specific to the SCN9A‐mutation and not to differences in pain intensity. Conclusion: Combined, these results suggest the potential involvement of a distinct structural pathway related to pain processing in SFN‐SCN9A.

  • A Multinational Study of Patient and Caregiver‐Reported Insights Into ADSS1 Myopathy

    by Merve Koç Yekedüz, Yunjung Choi, Soo‐Hyun Kim, Raquel van Gool, Hanne van der Heijden, Lise Vrolix, Buket Sonbas Cobb, Seward Rutkowe, Julie Shulman, Alan Beggs, et al.

    Introduction/Aims: Adenylosuccinate synthase‐like 1 (ADSS1) myopathy is an ultra‐rare disorder caused by biallelic pathogenic variants in the ADSS1 gene. This results in progressive muscle weakness, fatigue, dysphagia, and, in severe cases, cardiomyopathy and respiratory failure. The aim of the study was to evaluate how ADSS1 myopathy impacts patients' lives and to comprehensively assess their quality of life. Methods: We conducted individual interviews in 31 participants with ADSS1 myopathy from six countries. Participants engaged in structured interviews, which included both open‐ended questions and the Individualized Neuromuscular Quality of Life (INQoL) questionnaire. Thematic analysis was employed to identify the primary concerns, symptoms, and quality‐of‐life challenges faced by patients. Results: From individual interviews, the decline in mobility and motor skills (54.8%) and muscle weakness (48.3%) primarily impacting the lower extremities emerged as the most frequently reported bothersome symptoms. The most reported concerns were decline in mobility, motor skills, and gait disturbance (58.0%). Only 5% of the patients reported no impact of ADSS1 myopathy on their work or social life. The INQoL questionnaire identified 20 patients (64.5%) with pain, with the most common location being the lower extremities, while fatigue was reported by all patients except one. The most identified treatment priorities were improving motor function (51.6%) and halting disease progression (48.3%). Discussion: This study highlights the significant physical and psychosocial burden of ADSS1 myopathy, with progressive muscle weakness and multisystem involvement affecting daily life. The findings underscore the need for early diagnosis and multidisciplinary care approaches.